A Mars lander’s digger is burrowing into the red planet again after hitting a snag seven months ago.
NASA on Thursday said that the mechanical mole has penetrated 2cm over the past week. While just a baby step, scientists are thrilled with the progress.
“We’re rooting for our mole to keep going,” lead scientist Tilman Spohn of the German Aerospace Center said in a statement.
The German device is meant to penetrate 5m into Mars to measure internal temperatures. It barely got 30cm down before stalling in March, soon after starting to hammer.
Over the weeks and months, engineers devised a backup plan: To help, the robot arm on the InSight lander is pressing against the drill to create enough friction for it to keep digging.
Since Tuesday last week, the mole has hammered 220 times on three occasions, making slow, but steady progress.
Scientists said it would take time — and lots more hammering — to see how deep it goes.
“When we first encountered this problem, it was crushing, but I thought: ‘Maybe there’s a chance — let’s keep pressing on,’ and right now I’m feeling giddy,’” said Troy Hudson of NASA’s Jet Propulsion Laboratory, which is leading the recovery effort.
InSight landed on Mars in November last year.
FAKE NEWS? ‘When the government demands the press become a state mouthpiece under the threat of punishment, something has gone very wrong,’ a civic group said The top US broadcast regulator on Saturday threatened media outlets over negative coverage of the Middle East war, after US President Donald Trump slammed critical headlines from the “Fake News Media.” The US president since his first term has derided mainstream media as “fake news” and has sued major outlets over what he sees as unfair coverage. Brendan Carr, head of the US Federal Communications Commission — which oversees the nation’s radio, television and Internet media — said broadcasters risked losing their licenses over news coverage. “The law is clear. Broadcasters must operate in the public interest, and they will
INFLUTENTIAL THEORIST: Habermas was particularly critical of the ‘limited interest’ shown by German politicians in ‘shaping a politically effective Europe Jurgen Habermas, whose work on communication, rationality and sociology made him one of the world’s most influential philosophers and a key intellectual figure in his native Germany, has died. He was 96. Habermas’ publisher, Suhrkamp, said he died on Saturday in Starnberg, near Munich. Habermas frequently weighed in on political matters over several decades. His extensive writing crossed the boundaries of academic and philosophical disciplines, providing a vision of modern society and social interaction. His best-known works included the two-volume Theory of Communicative Action. Habermas, who was 15 at the time of Nazi Germany’s defeat, later recalled the dawn of
The Chinese public maintains relatively warm sentiments toward Taiwan and strongly prefers non-military paths to improving cross-strait relations, a recent survey conducted by the Atlanta, Georgia-based Carter Center and Emory University showed. The “China Pulse” research project, which polled 2,506 adults between Oct. 27 last year and Jan. 1 this year, found that 86 percent of respondents support strengthening cultural ties, while 81 percent favor deepening economic interaction. The report, co-authored by political scientists at Emory University and advisors at the Carter Center, indicates that the Chinese public views Taiwan’s importance through a lens of shared history and culture rather than geopolitical
Cannabis-based medicines have shown little evidence of effectiveness for treating most mental health and substance-use disorders, according to a large review of past studies published in a major medical journal on Monday. Medical use of cannabinoids has been expanding, including in the US, Canada and Australia, where many patients report using cannabis products to manage conditions such as anxiety, post-traumatic stress disorder and sleep problems. Researchers reviewed data from 54 randomized clinical trials conducted between 1980 and May last year involving 2,477 participants for their analysis published in The Lancet. The studies assessed cannabinoids as a primary treatment for mental disorders or substance-use
RSS